AGIO
Agios Pharmaceuticals Inc
Price:  
32.32 
USD
Volume:  
857,858.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Agios Relative Valuation

-578.5%
Upside

As of 2024-03-01, the Relative Valuation of Agios Pharmaceuticals Inc (AGIO) is (154.66) USD. This relative valuation is based on P/E multiples. With the latest stock price at 32.32 USD, the upside of Agios Pharmaceuticals Inc based on Relative Valuation is -578.5%.

The range of the Relative Valuation is (146.15) - (153.08) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 23.2x - 29.4x 26.8x
Forward P/E multiples 19.8x - 24.3x 22.3x
Fair Price (146.15) - (153.08) (154.66)
Upside -552.2% - -573.6% -578.5%
32.32 USD
Stock Price
(154.66) USD
Fair Price

Agios Relative Valuation - Historical P/E Data

Date P/E
2024-02-29 -5.13
2024-02-28 -5.34
2024-02-27 -5.53
2024-02-26 -5.22
2024-02-23 -5.24
2024-02-22 -4.73
2024-02-21 -4.25
2024-02-20 -4.30
2024-02-16 -4.21
2024-02-15 -4.25
2024-02-14 -4.11
2024-02-13 -3.99
2024-02-12 -4.11
2024-02-09 -3.99
2024-02-08 -3.84
2024-02-07 -3.76
2024-02-06 -3.83
2024-02-05 -3.77
2024-02-02 -3.67
2024-02-01 -3.64
2024-01-31 -3.59
2024-01-30 -3.63
2024-01-29 -3.79
2024-01-26 -3.71
2024-01-25 -3.72
2024-01-24 -3.41
2024-01-23 -3.45
2024-01-22 -3.43
2024-01-19 -3.45
2024-01-18 -3.38
2024-01-17 -3.45
2024-01-16 -3.48
2024-01-12 -3.61
2024-01-11 -3.59
2024-01-10 -3.71
2024-01-09 -3.81
2024-01-08 -3.88
2024-01-05 -3.67
2024-01-04 -3.73
2024-01-03 -3.81
2024-01-02 -3.62
2023-12-29 -3.54
2023-12-28 -3.62
2023-12-27 -3.62
2023-12-26 -3.65
2023-12-22 -3.80
2023-12-21 -3.63
2023-12-20 -3.66
2023-12-19 -3.78
2023-12-18 -3.69